Articles

Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis

From the Departments of Stem Cell Transplantation and Cellular Therapy
Biostatistics
From the Departments of Stem Cell Transplantation and Cellular Therapy
From the Departments of Stem Cell Transplantation and Cellular Therapy
From the Departments of Stem Cell Transplantation and Cellular Therapy
From the Departments of Stem Cell Transplantation and Cellular Therapy
From the Departments of Stem Cell Transplantation and Cellular Therapy
From the Departments of Stem Cell Transplantation and Cellular Therapy
From the Departments of Stem Cell Transplantation and Cellular Therapy
From the Departments of Stem Cell Transplantation and Cellular Therapy
From the Departments of Stem Cell Transplantation and Cellular Therapy
From the Departments of Stem Cell Transplantation and Cellular Therapy
From the Departments of Stem Cell Transplantation and Cellular Therapy
From the Departments of Stem Cell Transplantation and Cellular Therapy
From the Departments of Stem Cell Transplantation and Cellular Therapy
Pharmacy
Pharmacy
Lymphoma and Myeloma
Lymphoma and Myeloma
Lymphoma and Myeloma
Lymphoma and Myeloma
Lymphoma and Myeloma
Lymphoma and Myeloma
Radiation Oncology
Radiation Oncology
Radiation Oncology
Pediatrics
Pediatrics
Pediatrics
Nuclear Medicine at the University of Texas MD Anderson Cancer Center
From the Departments of Stem Cell Transplantation and Cellular Therapy
From the Departments of Stem Cell Transplantation and Cellular Therapy
From the Departments of Stem Cell Transplantation and Cellular Therapy
Haematologica Early view May 6, 2021 https://doi.org/10.3324/haematol.2021.278311